Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

Inclusion Criteria: * Male or female 2 years of age or older * Clinical diagnosis of primary impetigo (bullous or non bullous) * Minimum diameter of Target Lesion to be one centimeter measured either as length or width. * Presence of at least one and no more than ten lesions per subject at the time of screening * The infected lesions' total area (as determined by the Investigator) must be less than 100 cm2 in total area for subjects 18 years of age or older, or up to a maximum of 2% total body surface area for subjects younger than 18 years of age. * Skin Infection Rating Scale (SIRS) total score of the Target Lesion of at least 4 Exclusion Criteria: * Presence of other active skin diseases at or near the Target Lesion area to be treated * A subject whose disease is so widespread or severe that, in the opinion of the investigator, oral antibiotic treatment is needed * Signs and symptoms of another current infection requiring antibiotic treatment * Tympanic temperature at Screening/Baseline exceeding 38 degrees Celsius (100.4 degrees Fahrenheit) in a pediatric subject or 37.8 degrees Celsius (100 degrees Fahrenheit) in an adult subject * History of Hepatitis B or C, HIV/ AIDS, or other immunodeficiency disease * Concurrent or recent scabies infection or lice infestation (pediculosis) of the scalp * Use of systemic antibiotics or systemic steroids within 14 days prior to study entry. A history of three or more courses of systemic antibiotics within the 3 month period immedia…